Analyst firms · Stifel · TNDM
Stifel TNDM price target and rating history
Tandem Diabetes Care Inc. (TNDM) · Health Care
Stifel rates Tandem Diabetes Care Inc. (TNDM) Buy with a $26 price target, as of its latest action on Nov 18, 2026. It has published 3 rating actions on TNDM since March 2024, including 2 upgrades and 0 downgrades. Across 12 firms with a TNDM price target in the last 12 months, the median target is $26.50. Stifel's $26 is 2% below that.
- Current rating
- Buy
- Price target
- $26
- Median target, all firms
- $26.50
- Actions on TNDM
- 3
Stifel price target on TNDM
Every Stifel rating on TNDM
- Nov 18, 2026
- Oct 21, 2025
- Mar 26, 2024
How other firms rate TNDM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Buy | $26 | Nov 18, 2026 |
| Barclays | Equal Weight | $18 | Oct 7, 2026 |
| Citigroup | Neutral | $20 | Sep 30, 2026 |
| William Blair | Outperform | Aug 21, 2026 | |
| UBS | Neutral | $18 | Jul 28, 2026 |
| Deutsche Bank | Hold | $15.50 | Jun 23, 2026 |
| Wells Fargo | Overweight | $27 | Jun 1, 2026 |
| The Benchmark Company | Hold | May 12, 2026 | |
| Truist Securities | Buy | $35 | Mar 19, 2026 |
| Piper Sandler | Overweight | $33 | Mar 17, 2026 |
| Lake Street | Buy | $50 | Feb 23, 2026 |
| BofA Securities | Neutral | $30 | Feb 20, 2026 |
| TD Cowen | Buy | $25 | Jan 27, 2026 |
| Robert W. Baird | Outperform | $30 | Dec 16, 2025 |
Questions about Stifel and TNDM
- What is Stifel's price target for TNDM?
- Stifel's latest stated price target for Tandem Diabetes Care Inc. (TNDM) is $26, from its action on Nov 18, 2026.
- What is Stifel's rating on TNDM?
- Stifel rates TNDM Buy, a bullish rating, as of Nov 18, 2026.
- When did Stifel last change its view on TNDM?
- On Nov 18, 2026, Stifel upgrades to Buy from Hold, price target $26.
- How does Stifel's TNDM target compare with other analysts?
- Across 12 firms with a TNDM price target in the last 12 months, the median target is $26.50. Stifel's $26 is 2% below that.
More TNDM rating histories
All Stifel ratingsTNDM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.